These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9665490)

  • 21. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.
    Hamilton SR; Smith RR; Cameron JL
    Hum Pathol; 1988 Aug; 19(8):942-8. PubMed ID: 3402983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
    Sanz-Ortega J; Hernández S; Saez MC; Sierra E; Sanz-Ortega G; Torres A; Balibrea JL; Sanz-Esponera J; Merino MJ
    Hepatogastroenterology; 2003; 50(50):404-7. PubMed ID: 12749233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas.
    Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Orii S; Itoh C; Katoh R
    Hum Pathol; 2000 Aug; 31(8):925-30. PubMed ID: 10987252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa.
    Portale G; Peters JH; Hagen JA; Demeester SR; Gandamihardja TA; Tharavej C; Hsieh CC; Demeester TR
    Arch Surg; 2005 Jun; 140(6):570-4; discussion 574-5. PubMed ID: 15967904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.
    Lu D; Vohra P; Chu PG; Woda B; Rock KL; Jiang Z
    Am J Surg Pathol; 2009 Apr; 33(4):521-5. PubMed ID: 19047899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and molecular biology of Barrett esophagus.
    Casson AG; Williams L; Guernsey DL
    Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic alterations in malignant transformation of Barrett's esophagus.
    Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
    Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
    Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
    Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.
    Gleeson CM; Sloan JM; McManus DT; Maxwell P; Arthur K; McGuigan JA; Ritchie AJ; Russell SE
    Br J Cancer; 1998; 77(2):277-86. PubMed ID: 9460999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
    Galipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJ
    PLoS Med; 2007 Feb; 4(2):e67. PubMed ID: 17326708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma of the esophagus with and without Barrett mucosa.
    Sabel MS; Pastore K; Toon H; Smith JL
    Arch Surg; 2000 Jul; 135(7):831-5; discussion 836. PubMed ID: 10896378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
    Cameron AJ; Souto EO; Smyrk TC
    Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Biomarkers for Human Papillomavirus With Survival Among Adults With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma.
    Rajendra S; Sharma P; Gautam SD; Saxena M; Kapur A; Sharma P; Merrett N; Yang T; Santos LD; Pavey D; Sharaiha O; McKay O; Dixson H; Xuan W
    JAMA Netw Open; 2020 Feb; 3(2):e1921189. PubMed ID: 32058552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
    Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.